1. Home
  2. TRT vs PMN Comparison

TRT vs PMN Comparison

Compare TRT & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trio-Tech International

TRT

Trio-Tech International

HOLD

Current Price

$4.92

Market Cap

35.1M

Sector

Technology

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$20.91

Market Cap

34.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRT
PMN
Founded
1958
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.1M
34.6M
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
TRT
PMN
Price
$4.92
$20.91
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$42.67
AVG Volume (30 Days)
53.2K
190.5K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
110.28
EPS
0.02
N/A
Revenue
$32,462,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$249.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.42
$0.29
52 Week High
$14.78
$20.22

Technical Indicators

Market Signals
Indicator
TRT
PMN
Relative Strength Index (RSI) 36.91 83.51
Support Level N/A $0.43
Resistance Level $5.79 N/A
Average True Range (ATR) 0.45 1.49
MACD 0.07 0.41
Stochastic Oscillator 25.49 97.21

Price Performance

Historical Comparison
TRT
PMN

About TRT Trio-Tech International

Trio-Tech International operates in the semiconductor industry, providing manufacturing, testing, and distribution services for semiconductor test equipment and electronic components. It has two main segments: Semiconductor Back-end Solutions (SBS) and Industrial Electronics (IE). The SBS segment, which generates the majority of the Company's revenue, focuses on manufacturing equipment for semiconductor back-end processes, offering testing services, and distributing burn-in test related equipment. The IE segment manufactures equipment for other industries and distributes electronic products outside the semiconductor sector. The Company operates in the United States, Singapore, Malaysia, Thailand, and China, serving customers across multiple regions.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: